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Introduction: Vital pulp therapy (VPT) aims to preserve the health and maintain life of the tooth 
pulp which has been compromised by caries, trauma or restorative procedures. Recently, enamel 
matrix derivative (EMD) has been introduced as a material for vital pulp therapy. The aim of this 
review is to critically analyze and summarize the available literature on EMD for VPT. Methods and 
Materials: Online databases (PubMED/MEDLINE, Google Scholar, ISI Web of Science, and Wiley-
Online) were searched by using the following keywords in various combinations: Enamel Matrix 
Derivative, Emdogain, ‘Vital Pulp Therapy, ‘Apexogenisis’, Apexification, Pulp Capping, Endodontics, 
Dentine and Pulpotomy for studies indexed from January 1949 to April 2016. We used an English-
limited search in Google.co.uk for the missing grey literature. All studies fulfilling the selection criteria 
were carefully reviewed for the focused question: “Does using EMD in VPT, compared with other 
materials, result in better clinical, radiographic and histological outcomes?”. Results: The primary 
search resulted in 18 articles of which, 14 articles (including 6 animal studies and 6 clinical trials and 
2 case reports) met the inclusion criteria for this review and hence were included. The number of 
teeth tested in the animal studies ranged from 8 to 144 including pigs, rats and dogs teeth. A number 
of studies used EMD in the experimental group in comparison with calcium hydroxide, propylene 
glycol alginate (PGA) and MTA as a control. The observation period ranged from 1 to 2 months and 
4 out of 6 animal trials reported more favorable outcomes with EMD while two studies reported 
comparable outcomes. Conclusion: Although EMD has potential for various applications in 
endodontics, studies conducted to date have failed to demonstrate any significant advantage of EMD 
over conventional VPT materials. Additionally, the 5-year and 10-year survival rate of EMD-treated 
teeth is not yet known. Hence, studies with a longer follow-up periods are required to deduce the 
long-term viability of teeth treated with EMD. 
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Introduction 
ital pulp therapy (VPT) aims to preserve the life of the 
healthy tooth pulp which has been compromised by caries, 
trauma or restorative procedures [1]. Following the removal of 
carious tooth structure, VPT can be carried out by various 
means [2]. Apexogenesis and apexification involve the induction 
of the development of the incomplete root and placement of an 
artificial barrier or calcifying agent in the open apex of the 
immature root respectively [3]. Depending on the extent of 
inflammation, the coronal pulp can be removed to different 
degrees (from partial to full coronal pulpotomy) [4]. 
Alternatively, the exposed pulp can be sealed by a biologic 
capping material, a process known as direct pulp capping (DPC) 
[5]. Following all these procedures, the tooth is restored with 
direct (e.g. resin composites, dental amalgam, glass ionomer 
cements, etc.) or indirect (e.g. porcelain and alloy crowns) 
restorative materials [2]. 
V
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Traditionally, calcium hydroxide (CH) has been the material 
of choice for direct pulp capping (DPC) [6, 7]. CH has the ability 
to induce the formation of dentine bridge to seal the pulp 
chamber. Additionally, the alkaline nature of the material is 
known to have an anti-bacterial and anti-cariogenic effect. 
However, CH has a number of drawbacks. For instance, the 
strong alkaline nature has been thought to induce pulpal 
necrosis, particularly in deciduous teeth [8-10]. Moreover, the 
efficacy of CH has been challenged by its poor sealing ability, 
rapid degradation and formation of defects in the underlying 
dentine bridge [11]. To overcome the aforementioned 
disadvantages of CH, new materials have been developed. These 
include mineral trioxide aggregate (MTA), a mixture of 
tricalcium silicate, tricalcium aluminate and bismuth oxide. 
Studies indicate that not only MTA induces faster and more 
marked formation of dentine bridges but it is also clinically 
easier to use [1, 7]. Nevertheless, weak points such as a 
prolonged setting time, potential of tooth discoloration and 
significantly higher cost than CH has limited its use [12]. 
Pulpotomy of primary teeth also involves the placement of 
materials such as formocresol and ferric sulphate in addition to 
MTA and CH following the removal of the coronal pulp [1]. 
However, due to high toxicity, the use of formocresol has been 
limited. Ferric sulphate and formocresol can irritate the pulp 
and are not suitable alternatives to biologic materials used for 
this purpose [13].  
More recently, enamel matrix derivative (EMD, Emdogain®) 
has been advocated for regeneration of dental tissues. EMD is an 
extract derived from porcine fetal tooth material and mainly 
consists of amelogenins, a class of proteins known to induce the 
growth and proliferation of periodontal ligament cells (PDL), 
along with propylene glycol alginate (PGA) as the degradable 
carrier [14, 15]. Hence, it has been used as an alloplastic guided 
tissue regeneration (GTR) material to restore periodontal 
defects [14, 16-19]. Additionally, animal studies have 
demonstrated that EMD is more effective than CH in inducing 
the formation of the dentine bridge and, hence, has the potential 
to be used in DPC and pulpotomy [20, 21]. Olsson et al. [22] 
have successfully used EMD for DPC material in 8 patients. 
Nevertheless, Yildirim et al. [23] have suggested that EMD has 
similar clinical efficacy to MTA, CH and formocresol. The aim 
of this review is to conclude all the studies regarding the efficacy 
of EMD as a VPT material in animal studies and human clinical 
trials. Therefore, the focused question for this review is: Does 
using EMD in VPT, compared with other materials (CH, MTA 
and formocresol), result in better clinical, radiographic and 
histological outcomes. 
Materials and Methods 
Search strategy 
The PubMED/MEDLINE, Google Scholar, ISI Web of Science, 
and Wiley-Online data bases were searched by using the 
following keywords in various combinations: Enamel Matrix 
Derivative, Emdogain, Vital Pulp Therapy, ‘Apexogenesis, 
Apexification, Pulp Capping, Endodontics, Dentine and 
Pulpotomy, for studies indexed from 1949 to April 2016. In order 
to search the missing grey literature, we used Google.co.uk and 
limited the search to English language. Additionally, the relevant 
articles obtained were read completely for any relevant citations 
and their reference lists were searched manually for any more 
pertinent articles. 
Inclusion and exclusion criteria 
The inclusion criteria for the aforementioned search was: 
Randomized control trials, case series and reports, retrospective 
studies, in vivo animal studies, bibliography of the original and 
review articles, and studies in English. Likewise the exclusion 
criteria were: Purely histological (in vitro) studies, 
commentaries, letters to the editor, unpublished articles. 
Appraisal of the literature 
All studies fulfilling the selection criteria were carefully reviewed 
to find the information related to the focused question; “Does 
using EMD in VPT, compared with other materials (CH, MTA 
and formocresol), result in better clinical, radiographic and 
histological outcomes. Any disagreement among authors was 
resolved by mutual discussion. The review findings are based on 
clinical, radiographic and histological outcomes, hence the 
studies reporting only histological findings were not included in 
the results. 
Results 
The primary search resulted in 18 articles. Of these, 14 articles 
met the inclusion criteria for this review and hence were 
included [20-34]. Three studies, not meeting the inclusion 
criteria, were excluded. Six studies were animal studies [20, 21, 
24-27] and eight studies were human trials [22, 23, 28-34]. Two 
clinical studies were case reports [31, 34]. The included studies 
have been listed in table 1 and table 2. Studies reporting only 
histological findings were excluded (Table 3). 
All animal studies [20, 21, 24-27] were in vivo experiential 
studies. The number of teeth tested in the animal studies ranged 
 
IEJ Iranian Endodontic Journal 2017;12(3): 269-275 
271 Enamel matrix derivative in vital pulp therapy 
from 8 to 144. Three studies used pigs [20, 21, 27], two studies 
used rats [25, 26] and one study used dogs [24] as test subjects. 
Five studies used EMD in the test group [20, 21, 24, 25, 27]. Two 
studies used CH, one study used propylene glycol alginate 
(PGA) [25] and one study used MTA as control treatments [27]. 
One study compared the efficacy of EMD, MTA, platelet-rich 
plasma (PRP) and CH with that of untreated teeth as negative 
controls [26]. The observation period ranged from 1 to 2 months 
[20, 21, 24-27]. Four out of 6 animal studies reported more 
favorable outcomes with EMD [20, 21, 24, 25] while two studies 
resulted in comparable outcomes [26, 27]. A number of studies 
[20, 21, 25] showed dentine formation significantly higher in the 
experimental group compared to the control. While a few 
studies [24, 26, 27] showed dentin formation in both groups 
without any remarkable differences. 
In eight human studies [22, 23, 28-34], the number of 
subjects ranged from 1 to 65 and number of teeth treated with 
EMD ranged from 1 to 140. The follow-up period ranged from 
3 to 24 months and reported clinical and radiographic findings 
of the treated teeth [22, 23, 28-34]. Two studies [22, 32] assessed 
clinical, radiographic and histological outcomes after VPT with 
EMD. Five studies assessed clinical and radiographic outcomes 
[23, 29-31, 34]. Meanwhile, two studies only evaluated the 
histological outcomes [28, 33]. Four studies compared the 
efficacy of EMD for DPC in comparison with CH [22]. In three 
studies, EMD was used for pulpotomy [23, 28, 29] among which 
one study did not use any control [28], one used formocresol as 
control [29] while one study used MTA, formocresol and 
Portland cement as controls [23]. In one case report, EMD was 
used in combination with deproteinated bovine bone (Bio-Oss®) 
for apexification [34]. Olsson et al. [22] and Kiatwateeratana et 
al. [32], indicated that EMD was more effective in inducing the 
formation of the dentine bridge while Fransson et al. [33], 
observed more mineralization when CH was used. All studies 
resulted in comparable clinical and radiographic outcomes 
except the one by Olsson et al. [22] and Sabbarini et al. [29], who 
had found significantly better outcomes with EMD. These 
clinical and radiographic findings have been reported on the 
basis of a very short follow-up period (3 to 24 months). More 
studies with longer follow period and clinical tails are essential 
to establish conclusive find about the effect of EMD on pulp 
tissues.  
Discussion 
The primary constituent of EMD is amelogenin, a group of 
proteins consisting of ameloblastins, enamelins and tuftelins, all 
of which have been known to induce tooth formation [38-40]. 
Additionally, the presence of growth factors such as tissue 
transforming growth factor beta-1 (TGF-β) in EMD have also 
been known to stimulate mineralization [41]. Despite the proven 
in vitro effects, EMD has been used for VPT in only a few human 
and animal studies to date [20-34]. 
Table 1. A summary of animal studies conducted to test the efficacy of enamel matrix derivative placed over exposed pulp 







Observations and conclusions 
Nakamura et al. [20] In vivo  4 pigs 22  CH EMD ∼1 month 
Dentine formation significantly higher 
in test group. 
Nakamura et al. [21] In vivo  11 pigs 36  CH EMD ∼2 months 
Dentine formation significantly higher 
in test group. 
Ishizaki et al. [24] In vivo  2 dogs 8  
No 
treatment 
EMD ∼2 months 
Dentine formation observed in test 
group. 
Igarashi et al. [25] In vivo  Rats 47 PGA EMD ∼1 month 
Dentine formation significantly higher 
in test group. 








Dentine formation comparable in all 
groups 
Bajić et al. [27] In vivo  1 pig 20 MTA EMD ∼1 month 
Dentine formation comparable in all 
groups. No difference in inflammation 
or presence of bacteria. 
EMD, enamel matrix derivative; Ca(OH)2, calcium hydroxide; MTA, mineral trioxide aggregate; PRP, platelet-rich plasma; PGA, propylene glycol alginate 
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Table 2. A summary of clinical studies conducted to test the efficacy of enamel matrix derivative placed over exposed pulp 































formation of dentine 
bridge and resulted in 
lesser post-op 
symptoms than CH. 
More inflammation in 
pulp capped with 
EMD. 














Sabbarini et al. 
[29] 
Clinical, 

















1 1 primary 
molar 
N/A EMD 12 
months 
No complications 












CH EMD 12 
months 
2 treatments failed (1 
control, 1 test). 















CH induced more 
dentine bridge 




in both groups. 






CH EMD ∼3 months 
More mineralization 
observed in control 
group. More 
inflammation observed 
in teeth capped with 
EMD. 
Razavian et al. [34] 
Clinical, 
radiographic 






Complete closure of 
apex. No 
complications 
observed at follow-up.  
Yildirim et al. [23] 
Clinical, 













comparable in all 
groups. 
EMD, enamel matrix derivative; CH, calcium hydroxide; MTA, mineral trioxide aggregate 
Table 3. List of studies excluded from this review 
Author and year Reason for exclusion 
Lee et al. [35] Only histological study 
Min et al. [36] Only histological study 
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Before biomaterials can be used to treat humans, conducting 
meticulous in vitro and in vivo testing are essential [42]. Indeed, 
as shown in table 1, some animal studies suggest that EMD is 
more effective than CH [20,21] and MTA [27]. However, the 
study by Orhan et al. [26] has found no difference between the 
number of osteoblasts and thickness of dentine in teeth capped 
with EMD, CH, MTA and PRP. Hence, judging the superiority 
of EMD over other materials in VPT, solely by animal studies, is 
debatable. It is not possible to carry out long-term animal studies 
and, hence, none of the animal studies have been observed for 
more than 2 months [20, 21, 24-27]. Furthermore, all animal 
studies have used non-carious teeth. Thus, the long-term 
viability of EMD-treated teeth cannot be deduced from these 
animal studies.  
Histological evaluation of human capped teeth have not 
found any conclusive evidence of EMD being superior to other 
commercially available pulp-capping materials. Olsson et al. 
[22] and Kiatwateeratana et al. [32] have found comparable 
dentine bridge thickness regardless of the capping material. 
Fransson et al. [33] have detected higher levels of expression of 
dentine sialoprotein (DSP) and collagen I, biomarkers indicative 
of odontoblast proliferation and dentine formation [43], in 
human pulp capped with EMD than those capped with CH. On 
the other hand, a higher level of inflammation of observed with 
EMD [22, 32, 33] is suggestive of better performance of CH as a 
pulp capping material. To date, there are no published long-
term studies to evaluate the histological effects of EMD on 
human pulp. 
Clinical and radiographic outcomes suggest that the efficacy 
of EMD is comparable to other pulp capping and pulpotomy 
materials which include CH, MTA, Portland cement and ferric 
sulfate [22, 23, 28-34]. Similar conclusions were drawn in a 
systemic review by Al-Hezaimi et al. [44]; however, the review 
assessed the efficacy of EMD against CH. Although short-term 
studies indicated that EMD produces lesser post-operative 
symptoms than CH [22], clinical and radiographic outcomes 
assessed from 6 to 24 months are comparable regardless of the 
material used [30-32]. The outcomes of the clinical studies could 
be the result of the sealing abilities of the restorative materials 
placed on top of the capping materials. Indeed it has been 
observed previously that an intact marginal seal is necessary to 
prevent bacterial leakage and subsequent contamination of the 
pulp [45]. It has been observed that prompt permanent 
restoration of teeth following pulp capping, improves the 
outcomes regardless of the capping material used [43]. Hence, 
the efficacy of EMD and CH could be due to the sealing effects 
of the restorative materials rather than the dentine bridge 
formation. Sabbarini et al. [29] have shown that EMD has 
significantly better results than formocresol after 6 months. 
However, Yildirim et al. [23] have failed to observe any 
significant advantage of EMD over formocresol, MTA and 
Portland cement after 2 years of follow-up. These results suggest 
that although EMD may produce better outcomes after the first 
few months of placement, its efficacy decreases with time which 
could be attributed to the inflammatory effects of EMD observed 
in the aforementioned studies [22, 32, 33]. Indeed, factors such 
as dentine debris and resin particulates may impede the 
formation of dentin bridges as they may be a source of bacterial 
contamination and inflammation [46, 47]. None of the studies 
reviewed in this review involved pulpal exposures of more than 
2 mm [22, 23, 28-34]. Small pulpal exposures would prevent 
bacterial contamination and may contribute to the success rate 
of DPC procedures. The gross pulpal exposures are routinely 
encountered and more deleterious to the pulp. Hence, 
subsequent clinical trials involving EMD need to involve larger 
pulpal exposures to be more clinically significant. Razavian et al. 
[34] suggested that EMD and bovine bone (Bio Oss) 
combination, induced apical closure. Nevertheless, it is not 
known whether the effects is synergistic or solely due to EMD or 
Bio Oss. The EMD and Bio Oss are known to promote 
proliferation of dental pulp cells in vitro [48]. 
In prior studies, PGA, the carrier for EMD, has also been 
shown to exert an anti-bacterial effect against microorganisms 
present in dental plaque [49, 50]. Also, although not as high as in 
teeth capped with EMD, Igarashi et al. [25] also observed dentine 
formation in exposed pulp capped with just PGA. These studies 
indicate that the efficacy of EMD could be attributed to its carrier 
as well as amelogenins present in it. The 5 years success rate of 
DPC is 37% and can be as low as 13% after 10 years [51]. Because 
the maximum follow-up period recorded in the studies in this 
review is 24 months, it is difficult to deduce the long-term 
prognosis of teeth treated with EMD. More studies with longer 
follow period and clinical tails are essential to establish conclusive 
find about the effect of EMD on pulp tissues. 
Conclusion 
Although EMD has potential in various applications in 
endodontics, studies conducted to date have failed to 
demonstrate any significant advantage of EMD over 
conventional VPT materials. Additionally, the 5-year and 10-
year survival rate of EMD-treated teeth is not yet known. Hence, 
studies with a longer follow-up period are required to deduce the 
long-term viability of teeth treated with EMD. 
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